Xiuhui Shi

1.3k total citations · 1 hit paper
21 papers, 862 citations indexed

About

Xiuhui Shi is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Xiuhui Shi has authored 21 papers receiving a total of 862 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 9 papers in Cancer Research and 5 papers in Surgery. Recurrent topics in Xiuhui Shi's work include Cancer-related molecular mechanisms research (6 papers), MicroRNA in disease regulation (5 papers) and RNA modifications and cancer (5 papers). Xiuhui Shi is often cited by papers focused on Cancer-related molecular mechanisms research (6 papers), MicroRNA in disease regulation (5 papers) and RNA modifications and cancer (5 papers). Xiuhui Shi collaborates with scholars based in China and United States. Xiuhui Shi's co-authors include Ruizhi He, Xingjun Guo, Shutao Pan, Jingxuan Yang, Zhijun Zhou, Mingyang Liu, Min Li, Chao Xu, Courtney W. Houchen and Wenyi Luo and has published in prestigious journals such as Gastroenterology, Cancer Cell and Cancer Research.

In The Last Decade

Xiuhui Shi

20 papers receiving 852 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The crosstalk between macrophages and cancer cells potentiates pancreatic cancer cachexia

2024 60 citations Mingyang Liu, Yu Ren et al. Cancer Cell profile →

Peers

Countries citing papers authored by Xiuhui Shi

Since Specialization

Citations

This map shows the geographic impact of Xiuhui Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiuhui Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiuhui Shi more than expected).

Fields of papers citing papers by Xiuhui Shi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiuhui Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiuhui Shi. The network helps show where Xiuhui Shi may publish in the future.

Co-authorship network of co-authors of Xiuhui Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Xiuhui Shi. A scholar is included among the top collaborators of Xiuhui Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiuhui Shi. Xiuhui Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Abstract 5262: A zinc transporter drives pancreatic cancer cachexia via the crosstalk between tumor cells and immune microenvironment 2025 ·Cancer Research ·Zhijun Zhou, Mingyang Liu, Yu Ren, Jingxuan Yang, Xiuhui Shi, Yang Cai, (unknown), Wenyi Luo, Kar‐Ming Fung, Chao Xu, Ryan David Nipp, Michael S. Bronze, Lei Zheng, Yi‐Ping Li, Courtney W. Houchen, Yuqing Zhang, Min Li	0
2	Protocol for establishing and evaluating a cancer cachexia mouse model 2024 ·STAR Protocols ·Zhijun Zhou, Jingxuan Yang, Mingyang Liu, Yu Ren, Xiuhui Shi, Yang Cai, (unknown), Yiping Li, Yuqing Zhang, Min Li	4
3	The crosstalk between macrophages and cancer cells potentiates pancreatic cancer cachexia breakdown → 2024 ·Cancer Cell ·Mingyang Liu, Yu Ren, Zhijun Zhou, Jingxuan Yang, Xiuhui Shi, Yang Cai, (unknown), Wenyi Luo, Kar‐Ming Fung, Chao Xu, Ryan David Nipp, Michael S. Bronze, Lei Zheng, Yi‐Ping Li, Courtney W. Houchen, Yuqing Zhang, Min Li	60
4	Perturbation of Wnt/β‐catenin signaling and sexual dimorphism in non‐alcoholic fatty liver disease 2022 ·Hepatology Research ·Matthew M. Yeh, Xiuhui Shi, Jingxuan Yang, Min Li, Kar‐Ming Fung, Sayed S. Daoud	2
5	Acetyl-Coenzyme A Synthetase 2 Potentiates Macropinocytosis and Muscle Wasting Through Metabolic Reprogramming in Pancreatic Cancer 2022 ·Gastroenterology ·Zhijun Zhou, Yu Ren, Jingxuan Yang, Mingyang Liu, Xiuhui Shi, Wenyi Luo, Kar‐Ming Fung, Chao Xu, Michael S. Bronze, Yuqing Zhang, Courtney W. Houchen, Min Li	30
6	Circular RNA ANAPC7 Inhibits Tumor Growth and Muscle Wasting via PHLPP2–AKT–TGF-β Signaling Axis in Pancreatic Cancer 2022 ·Gastroenterology ·Xiuhui Shi, Jingxuan Yang, Mingyang Liu, Yuqing Zhang, Zhijun Zhou, Wenyi Luo, Kar‐Ming Fung, Chao Xu, Michael S. Bronze, Courtney W. Houchen, Min Li	81
7	Hypoxia activated HGF expression in pancreatic stellate cells confers resistance of pancreatic cancer cells to EGFR inhibition 2022 ·EBioMedicine ·Xiuhui Shi, Min Wang, Yuqing Zhang, Xingjun Guo, Mingyang Liu, Zhijun Zhou, Yan Zhao, Ruizhi He, Yang Gao, Yuhui Liu, Shutao Pan, Min Zhou, Chunle Zhao, Taoyuan Yin, Xu Li, Hebin Wang, Jingxuan Yang, Feng Zhu, Min Li, Renyi Qin	24
8	ZIP4 promotes non-small cell lung cancer metastasis by activating snail-N-cadherin signaling axis 2021 ·Cancer Letters ·Yuanyuan Jiang, Hanxiang Zhan, Yuqing Zhang, Jingxuan Yang, Mingyang Liu, Chao Xu, (unknown), Junxia Zhang, Zhijun Zhou, Xiuhui Shi, Rajagopal Ramesh, Li Min	19
9	MTAP Deficiency–Induced Metabolic Reprogramming Creates a Vulnerability to Cotargeting De Novo Purine Synthesis and Glycolysis in Pancreatic Cancer 2021 ·Cancer Research ·Qiangsheng Hu, Yi Qin, Shunrong Ji, Xiuhui Shi, Weixing Dai, Guixiong Fan, Shuo Li, Wenyan Xu, Wensheng Liu, Mengqi Liu, Zheng Zhang, Ye Zeng, Zhijun Zhou, Jingxuan Yang, Qifeng Zhuo, Xianjun Yu, Min Li, Xiaowu Xu	31
10	Zinc-Dependent Regulation of ZEB1 and YAP1 Coactivation Promotes Epithelial-Mesenchymal Transition Plasticity and Metastasis in Pancreatic Cancer 2021 ·Gastroenterology ·Mingyang Liu, Yuqing Zhang, Jingxuan Yang, Hanxiang Zhan, Zhijun Zhou, Yuanyuan Jiang, Xiuhui Shi, (unknown), Junxia Zhang, Wenyi Luo, Kar‐Ming Fung, Chao Xu, Michael S. Bronze, Courtney W. Houchen, Min Li	133
11	Inhibition of PI3K/AKT signaling via ROS regulation is involved in Rhein-induced apoptosis and enhancement of oxaliplatin sensitivity in pancreatic cancer cells 2021 ·International Journal of Biological Sciences ·Yuhui Liu, Chengjian Shi, Zheng He, Feng Zhu, Min Wang, Ruizhi He, Chunle Zhao, Xiuhui Shi, Min Zhou, Shutao Pan, (unknown), Li Xu, Renyi Qin	62
12	An integrated model of N6-methyladenosine regulators to predict tumor aggressiveness and immune evasion in pancreatic cancer 2021 ·EBioMedicine ·Zhijun Zhou, Junxia Zhang, Chao Xu, Jingxuan Yang, Yuqing Zhang, Mingyang Liu, Xiuhui Shi, Xiaoping Li, Hanxiang Zhan, Wei Chen, Lacey R. McNally, Kar‐Ming Fung, Wenyi Luo, Courtney W. Houchen, Yulong He, Changhua Zhang, Min Li	42
13	TFEB-driven autophagy potentiates TGF-β induced migration in pancreatic cancer cells 2019 ·Journal of Experimental & Clinical Cancer Research ·Ruizhi He, Min Wang, Chunle Zhao, Ming Shen, Yahong Yu, Li He, Yan Zhao, Hua Chen, Xiuhui Shi, Min Zhou, Shutao Pan, Yuhui Liu, Xingjun Guo, Li Xu, Renyi Qin	62
14	Long noncoding RNA LINC01111 suppresses pancreatic cancer aggressiveness by regulating DUSP1 expression via microRNA-3924 2019 ·Cell Death and Disease ·Shutao Pan, Ming Shen, Min Zhou, Xiuhui Shi, Ruizhi He, Taoyuan Yin, Min Wang, Xingjun Guo, Renyi Qin	52
15	Loss of Linc01060 induces pancreatic cancer progression through vinculin-mediated focal adhesion turnover 2018 ·Cancer Letters ·Xiuhui Shi, Xingjun Guo, Xu Li, Min Wang, Renyi Qin	26
16	Alantolactone induces apoptosis and improves chemosensitivity of pancreatic cancer cells by impairment of autophagy-lysosome pathway via targeting TFEB 2018 ·Toxicology and Applied Pharmacology ·Ruizhi He, Xiuhui Shi, Min Zhou, Yan Zhao, Shutao Pan, Chunle Zhao, Xingjun Guo, Min Wang, Li Xu, Renyi Qin	48
17	A Five-microRNA Signature for Survival Prognosis in Pancreatic Adenocarcinoma based on TCGA Data 2018 ·Scientific Reports ·Xiuhui Shi, Xu Li, Hang Zhang, Ruizhi He, Yan Zhao, Min Zhou, Shutao Pan, Chunle Zhao, Yechen Feng, Min Wang, Xingjun Guo, Renyi Qin	41
18	Meta-analysis on resected pancreatic cancer: a comparison between adjuvant treatments and gemcitabine alone 2018 ·BMC Cancer ·Hua Chen, Ruizhi He, Xiuhui Shi, Min Zhou, Chunle Zhao, Hang Zhang, Renyi Qin	6
19	Three-lncRNA signature is a potential prognostic biomarker for pancreatic adenocarcinoma 2018 ·Oncotarget ·Xiuhui Shi, Yan Zhao, Ruizhi He, Min Zhou, Shutao Pan, Shuo Yu, Yu Xie, Xu Li, Min Wang, Xingjun Guo, Renyi Qin	26
20	LncRNA AFAP1-AS1 promotes growth and metastasis of cholangiocarcinoma cells 2017 ·Oncotarget ·Xiuhui Shi, (unknown), Min Wang, Xiaodong Xu, Yan Zhao, Ruizhi He, Min Zhang, Min Zhou, Xu Li, Feng Peng, Chengjian Shi, Ming Shen, Xin Wang, Xingjun Guo, Renyi Qin	55

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact